Chung Hwa Bio: March 2026 Revenue Reaches 131 Million (Up 108.9% Year-on-Year)
NQ Score
4/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Chung Hwa Bio (stock code: 1762) announced its March 2026 monthly revenue of 131.435 million JPY, a significant 108.9% increase compared to the same period last year. This strong performance highlights the company's robust growth within the biotechnology and medical sector.
AI Analysis
Frequently Asked Questions
- Q: What was Chung Hwa Bio's revenue in March 2026?
- A: Chung Hwa Bio's monthly revenue in March 2026 was 131,435,000 JPY (131.435 million JPY).
- Q: How much did the revenue increase compared to the same month last year?
- A: It increased by 108.9% compared to the same month last year.
- Q: What kind of business does Chung Hwa Bio operate in?
- A: Chung Hwa Bio operates in the biotechnology and medical industry.